Centre Hospitalier Universitaire UCLouvain Namur
16
3
3
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.3%
1 terminated/withdrawn out of 16 trials
87.5%
+1.0% vs industry average
13%
2 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Effect of IMT in Patients After Acute Exacerbations of COPD
Role: collaborator
Phase IIb Study Evaluating Immunogenic Chemotherapy Combined with Ipilimumab and Nivolumab in Breast Cancer
Role: collaborator
OCT Guided Magmaris RMS in STEMI
Role: collaborator
Severe Acute Respiratory Infections (SARI) in Belgium (2011-2020)
Role: collaborator
Comparison of Mechanomyographic 100 Versus 200 Hz 5 Second Tetanic Fade Ratios During Neuromuscular Block Recovery
Role: lead
The BLIMP Balloon in Coronary Interventions
Role: collaborator
Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance Technologies
Role: lead
Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.
Role: collaborator
Carriage of Streptococcus Pneumoniae in Infants With Acute Otitis Media and in Infants Attending Day-care Centers
Role: collaborator
Functional Characterisation of Post-stroke Fatigue
Role: collaborator
Prognostic Impact of Tumor Growth Velocity in Head and Neck Squamous Cell Carcinoma Treated by Radio(Chemo)Therapy
Role: lead
Long Term Effects of Soft Splints on Stroke Patients and Patients With Disorders of Consciousness
Role: collaborator
Assessment of Reactance Parameters Measured by the Forced Oscillation Technique for the Bronchodilator Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Role: lead
Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR)
Role: collaborator
Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis
Role: collaborator
CAREGIVER2, Caregiver's Health Assessment : Clinical and Biological Markers
Role: lead
All 16 trials loaded